Wird geladen...
Gefitinib for Patients with Incurable Cutaneous Squamous Cell Carcinoma A Single Arm Phase II Clinical Trial
BACKGROUND: Pre-clinical data demonstrate a key role for the epidermal growth factor receptor (EGFR) in the carcinogenesis of cutaneous squamous cell carcinomas (CSCC). There is, however, limited data on the efficacy of EGFR inhibitors in incurable, recurrent and/or metastatic CSCC. OBJECTIVE: To de...
Gespeichert in:
| Veröffentlicht in: | J Am Acad Dermatol |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5685879/ https://ncbi.nlm.nih.gov/pubmed/28964539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2017.07.048 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|